Concepedia

Lingzhan Meng

LM

Statistics

Publications

3

Citations

65

H-Index

3

Active since

2021

Affiliations

First People's Hospital of Chongqing(Current)

Lingzhan Meng is an author at First People's Hospital of Chongqing specializing in oncology, medicine, and pharmacology.

Publications per year

2021–2024

3

Publications

3

A randomized, double-blinded, phase III study of icaritin versus huachashu as the first-line therapy in biomarker-enriched HBV-related advanced hepatocellular carcinoma with poor conditions: Interim analysis result.

Yan Sun, Shukui Qin, Wei Li et al. · Journal of Clinical Oncology · 2021 · 30 citations

Medicine, Oncology, Pharmacology +12

Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation

Junjun Ling, Yuhong Wang, Lihai Ma et al. · Evidence-based Complementary and Alternative Medicine · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study

He Li, Lingzhan Meng, Simiao Yu et al. · Hepatology International · 2024 · 15 citations · Full text

Medicine, Oncology, Surgery +17

1–3 of 3